REQUEST A DEMO
Total
USD $0.00
Search more companies

Novo Nordisk Pharma (Malaysia) Sdn. Bhd. (Malaysia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Securities and Commodity Exchanges | Marketing Research and Public Opinion Polling
Full name: Novo Nordisk Pharma (Malaysia) Sdn. Bhd. Profile Updated: February 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Novo Nordisk Pharma (Malaysia) Sdn. Bhd. is a company in Malaysia, with a head office in Kuala Lumpur. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. Novo Nordisk Pharma (Malaysia) Sdn. Bhd. was incorporated on May 21, 1992. In its most recent financial highlights, the company reported a net sales revenue increase of 17.76% in 2022. Over the same period, its total assets grew by 29.79%. The net profit margin of Novo Nordisk Pharma (Malaysia) Sdn. Bhd. increased by 0.02% in 2022.

Headquarters
Menara 1 Sentrum, Level 16, No 201, Jalan Tun Sambanthan
Kuala Lumpur; Federal Territories; Postal Code: 50470

Contact Details: Purchase the Novo Nordisk Pharma (Malaysia) Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Novo Nordisk Pharma (Malaysia) Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Novo Nordisk Pharma (Malaysia) Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Novo Nordisk Pharma (Malaysia) Sdn. Bhd. report to view the information.
Incorporation Date:
May 21, 1992
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Novo Nordisk Pharma (Malaysia) Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
17.76%
Total operating revenue
17.76%
Operating profit (EBIT)
17.81%
Net Profit (Loss) for the Period
18.49%
Total assets
29.79%
Total equity
35.77%
Operating Profit Margin (ROS)
0%
Net Profit Margin
0.02%
Return on Equity (ROE)
-3.84%
Quick Ratio
0.01%
Cash Ratio
-0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?